The disease is responsible for recurrent ringworms in children 1-4 and erythematous, squamous, and pruritic lesions in adults. 1,3 In the scalp, two aspects were described: (1) squamous alopecic, or (2) nodular (present case). 1,3 Scalp ulceration was reported only once. 2 At a later stage, lesions become deeper (nodules or subcutaneous abscesses). 4 Nail involvement is almost constant. 1-3 Dissemination to lymph nodes, bones, brain, or lung may be resistant to treatment and fatal. 4 Mycological cultures usually grow Trichophyton violaceum. 1-3 The isolated species in our patient, Trichophyton rubrum, was reported in 8% of cases. 2 The most common histological finding from cutaneous and lymphatic sites is a nonspecific granuloma. 2 Thus, the diagnosis is usually based on genetic examination. It is reported that CARD9 protein's deficit weakens immunity against dermatophytes and causes DD. 2 Among the identified mutations, Q289X (our case) was reported in five Algerian and two Tunisian families. 2 The treatment of DD relies on long-term oral antifungals. 1 The first-line, griseofulvin, shows high rates of recurrences and resistances. 1-3 Itraconazole (200 mg/day) can be sporadically efficient. Treatment failures can be life threatening. 1-3 Surgical treatment is efficient in cerebral or lymphatic involvement. 4,5 Further studies are needed to characterize the involvement of the CARD9 protein in the antifungal immune defenses and to optimize the management of DD, the prognosis of which can be serious.